Anxiety and Generalized Anxiety Disorder in Elite Athletes
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Pires, Laura
- Gomes, Sofia
Unidades de investigação
Abstract
Physical activity is recommended as a strategy for promoting mental health, and it can even be integrated into treatment plans for psychiatric disorders affecting the general population. However, elite athletes are a subpopulation with protective and risk factors inherent to high-level competition and are not shielded from psychiatric symptoms and conditions. The mental health of elite athletes has been the subject of increasing attention, driven in part by the initiatives of the International Olympic Committee and the growing importance of sports psychiatry. This article is a narrative review that provides an overview regarding anxiety, in particular generalized anxiety disorder in elite athletes. Our assessment concluded that competitive anxiety may affect an elite athlete's performance in both harmful and beneficial ways. Assessing the duration, frequency, and functional impact of anxiety symptoms is crucial for ruling out generalized anxiety disorder. Elite athletes do not show a significantly different prevalence of generalized anxiety disorder compared to the general population. Identifying specific protective and risk factors can contribute to adopting more effective preventive and intervention strategies. As in the general population, psychotherapy is recommended for elite athletes as the initial treatment for this condition, combined, if necessary, with pharmacotherapy, according to the World Anti-Doping Agency Code.
Dados da publicação
- ISSN/ISSNe:
- 1646-0758, 1646-0758
- Tipo:
- Article
- Páginas:
- -
- DOI:
- 10.20344/amp.21600
- PubMed:
- 39546464
Acta Medica Portuguesa CELOM
Documentos
- Não há documentos
Filiações
Keywords
- Anxiety; Anxiety Disorders; Athletes; Sports
Projetos associados
Metabolic syndrome is a main determinant of quality of life after metabolic surgery
Investigador Principal: Paula Isabel Marques Simões de Freitas
Estudo Clínico Académico (Metabolic syndrome) . 2023
The impact of integrase inhibitors on the development of hepatic steatosis and fibrosis in HIV-monoinfected patients
Investigador Principal: Paula Isabel Marques Simões de Freitas
Estudo Clínico Académico (Hepatic Steatosis) . 2023
Obesity and Cancer: the profile of a population who underwent bariatric surgery
Investigador Principal: Paula Isabel Marques Simões de Freitas
Estudo Clínico Académico . 2021
The role of gut microbiota-host interaction in obesity and metabolic disturbances
Investigador Principal: Paula Isabel Marques Simões de Freitas
Estudo Clínico Académico . 2020
Citar a publicação
Pires L,Gomes S,Freitas P. Anxiety and Generalized Anxiety Disorder in Elite Athletes. Acta Med. Port. 2024. IF:1,200. (4).
Portal de investigação
